01 /What it is
MK-677 (also called Ibutamoren) is a small molecule growth hormone secretagogue developed in the 1990s. It is not technically a peptide but is universally referenced inside the peptide research category because its mechanism is the same ghrelin receptor pathway studied by GHRPs such as Ipamorelin and Hexarelin.
02 /How it works
In research models, MK-677 is studied as an orally bioavailable agonist at the ghrelin (GHS-R1a) receptor. It is investigated for sustained signaling at this receptor in pulsatility research where peptide GHRPs would require repeated dosing.
03 /What researchers explore it for
Researchers have explored MK-677 in growth hormone secretagogue research, in oral bioavailability research at the ghrelin receptor, and in comparative research alongside peptide GHRPs.
04 /Safety and interactions
Research interactions of note include combinations with GHRH analogs and other ghrelin receptor agonists, which are commonly studied as overlapping pathways. MK-677 is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Compound family: small molecule growth hormone secretagogues. Frequently compared with Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The Apothify library lists MK-677 for encyclopedia coverage only.
Related peptides
Ipamorelin · GHRP-2 · Hexarelin